Growth Metrics

Plus Therapeutics (PSTV) Other Gross PP&E Adjustments (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Other Gross PP&E Adjustments for 15 consecutive years, with $1.6 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments rose 3.7% to $1.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 million through Dec 2025, up 3.7% year-over-year, with the annual reading at $1.6 million for FY2025, 3.7% up from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 was $1.6 million at Plus Therapeutics, up from -$20000.0 in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $1.6 million in Q4 2025, with the low at -$638000.0 in Q2 2021.
  • Average Other Gross PP&E Adjustments over 5 years is $107052.6, with a median of -$171000.0 recorded in 2024.
  • The sharpest move saw Other Gross PP&E Adjustments grew 2.53% in 2024, then skyrocketed 81.13% in 2025.
  • Over 5 years, Other Gross PP&E Adjustments stood at -$559000.0 in 2021, then surged by 337.39% to $1.3 million in 2022, then grew by 13.34% to $1.5 million in 2023, then increased by 2.53% to $1.5 million in 2024, then increased by 3.7% to $1.6 million in 2025.
  • According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at $1.6 million, -$20000.0, and -$29000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.